Home > Drug Search >
  • Targets: Superoxide dismutase (SOD)
  •   > 
Drug Filter
Category:
chemistry (13) biology (14)
Status:
Approved (9) Phase Ⅲ (2) Phase Ⅱ (10) Phase Ⅰ (6)
Clinical Stage:
Pending (5) Active (10) Discontinued (3)
Bio-Type:
Blood extraction (2) Recombinant enzyme (4) Recombinant glycoprotein (1) Other recombinant protein (2) Whole antibody (3)
Company:
Janssen (1) Pfizer (1) Salix Pharmaceutical (1) Sanofi (1) Shire (2) Takeda (1) The Medicines Company (1) Apeiron Biologics (1) Unknown (1) Vectura (1) Grifols (2) Kamada (1) Sanquin (1) Hyland Immuno (1) Polymun Scientific (1) Shin Poong Pharmaceutical (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Pharming Group (1) ActivBiotics (1) Quantum Genomic (1) MorphoSys (1) Aeolus Pharmaceuticals (1) Viron Therapeutics (1) Nektar (1) Galera (2) Baxalta (1) LAM (1) MetaPhore Pharmaceuticals (1) CSL Behring (2) VIRO Pharmaceuticals (1) ImmunoGen (1) Achaogen (1) Bayer (2) Celgene (1)
Indication:
Acute coronary syndrome (ACS) (1) Cancer chemotherapy (1) Cancer related pain (1) Cystic fibrosis (CF) (1) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Multiple myeloma (MM) (3) Angioedema (1) Postoperative pain (1) Peyronie's disease (1) Rheumatoid arthritis (RA) (1) Solid tumours (1) Systemic lupus erythematosus (1) Surgical blood loss (1) Radiodermatitis (1) Pain (1) Stroke (1) Disseminated intravascular coagulation (DIC) (1) Hereditary angioedema (HAE) (4) Oral mucositis (1) Septic shock (1) Gram-negative bacterial infection (1) Acute pancreatitis (1) Pulmonary fibrosis (1) Liver cancer (1) hematological malignancies (1) Alpha-1 antitrypsin deficiency (3) Organ failure (1) Stomatitis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top